Found: 9
Select item for more details and to access through your institution.
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 430, doi. 10.1007/s10637-021-01195-2
- By:
- Publication type:
- Article
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 6, p. 1906, doi. 10.1007/s10637-020-00948-9
- By:
- Publication type:
- Article
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 885, doi. 10.1007/s10637-020-00919-0
- By:
- Publication type:
- Article
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non‐small cell lung cancer harboring an EGFR mutation: A prospective observational study.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 4, p. 880, doi. 10.1111/1759-7714.13018
- By:
- Publication type:
- Article
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive‐disease small cell lung cancer in the elderly and patients with poor performance status.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 8, p. 967, doi. 10.1111/1759-7714.12772
- By:
- Publication type:
- Article
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8695, doi. 10.2147/CMAR.S339891
- By:
- Publication type:
- Article
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4911, doi. 10.2147/CMAR.S255552
- By:
- Publication type:
- Article
Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 4883, doi. 10.2147/CMAR.S207170
- By:
- Publication type:
- Article
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
- Published in:
- Oncology, 2018, v. 94, n. 4, p. 207, doi. 10.1159/000486038
- By:
- Publication type:
- Article